You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myelodysplastic Syndromes

Showing 51 - 75 of 3,174
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS, MDS, Thrombocytopenia Trial (Placebo, Romiplostim)

Completed
Has Results
  • MDS
  • +2 more
  • Placebo
  • Romiplostim
  • (no location specified)
Nov 4, 2022

Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,

Recruiting
  • Autoimmune Hemolytic Anemia
  • +5 more
  • cytokine essays
  • +6 more
  • Milano, Italy
    Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
Jul 3, 2023

Relapsed/Refractory Higher-Risk Myelodysplastic Syndrome, Relapsed/Refractory Acute Myeloid Leukemia Trial (Magrolimab)

Available
  • Relapsed/Refractory Higher-Risk Myelodysplastic Syndrome
  • Relapsed/Refractory Acute Myeloid Leukemia
  • Magrolimab
  • (no location specified)
Jan 18, 2023

MDS, Graft Vs Host Disease, Graft-versus-host-disease Trial in Miami (Busulfan, Melphalan, Fludarabine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Miami, Florida
    Miami Cancer Institute
Jan 10, 2023

MDS Trial in Saint Louis (DEC-C, MyeloSeq-HD)

Recruiting
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 18, 2023

Mean Platelet Volume and Its Relation to Risk Stratification of

Completed
  • Myelodysplastic Syndromes
    • (no location specified)
    Jan 21, 2022

    MDS, Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial in Pittsburgh (IFN-? (interferon gamma-1b) injection)

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • IFN-γ (interferon gamma-1b) injection
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jan 5, 2023

    MDS Trial in Saint Louis (vosaroxin, Azacitidine)

    Active, not recruiting
    • Myelodysplastic Syndromes
    • Saint Louis, Missouri
      Washington University School of Medicine
    Mar 23, 2022

    Physical Activity in Transfusion Dependent Myelodysplastic

    Recruiting
    • Myelodysplastic Syndromes
    • Medical Device Usage and Evaluation
    • +3 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Aug 16, 2022

    MDS Trial in Tampa (Canakinumab Injection, Darbepoetin Alfa)

    Recruiting
    • Myelodysplastic Syndromes
    • Canakinumab Injection
    • Darbepoetin Alfa
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 21, 2022

    MDS, Acute Myeloid Leukemia With Myelodysplasia Related Disease and < 30% Blasts, Mixed Myelodysplastic/Myeloproliferative

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Stockholm, Sweden
      Department of Hematology, Karolinska University Hospital
    Mar 27, 2023

    Strategy for High-Risk Myelodysplastic Syndromes in Patients

    Active, not recruiting
    • Myelodysplastic Syndromes
    • Allogeneic Stem Cell Transplantation
    • Agen, France
    • +9 more
    Jul 5, 2022

    Leukemia, MDS, Acute Myeloid Leukemia Trial in Houston (Cladribine)

    Not yet recruiting
    • Leukemia
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 28, 2023

    MDS Trial (Fasting-mimicking diet (FMD) and physiotherapy)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Fasting-mimicking diet (FMD) and physiotherapy
    • (no location specified)
    Jun 22, 2022

    MDS, Multiple Myeloma, Anemia Trial in France, Italy, United States (INCB000928)

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Palo Alto, California
    • +13 more
    Dec 12, 2022

    Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,

    Recruiting
    • Stem Cell Transplant Complications
    • +4 more
    • Radiation
    • +7 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 19, 2023

    Immune System Diseases, Autoimmune Diseases, Inflammation Trial (observational cohort study)

    Not yet recruiting
    • Immune System Diseases
    • +15 more
    • observational cohort study
    • (no location specified)
    Jul 23, 2023

    Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Cytokine Induced Memory-like Natural Killer Cells
    • Interleukin-2
    • Boston, Massachusetts
    • +1 more
    Nov 14, 2023

    Chronic Myelomonocytic Leukemia-0, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Houston

    Active, not recruiting
    • Chronic Myelomonocytic Leukemia-0
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 18, 2023

    Acute Myeloid Leukemia, MDS Trial (Galinpepimut-S)

    Available
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Galinpepimut-S
    • (no location specified)
    Oct 20, 2022

    Acute Myeloid Leukemia, MDS Trial in China (TQB2928 Injection + Azacitidine for injection)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • TQB2928 Injection + Azacitidine for injection
    • Beijing, Beijing, China
    • +8 more
    Aug 22, 2023

    MDS Trial in New York (selinexor (KPT-330))

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • selinexor (KPT-330)
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Feb 11, 2022

    MDS Trial (Yisui granule, Placebo)

    Not yet recruiting
    • MDS
    • Yisui granule
    • Placebo
    • (no location specified)
    Jan 13, 2023

    MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Sydney (Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET,

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET
    • Defactinib
    • Sydney, New South Wales, Australia
    • +3 more
    Jan 12, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +6 more
    • Miltenyi CliniMACS Prodigy ® system
    • (no location specified)
    Mar 23, 2023